Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 8 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
5(100.0%)
5Total
N/A(5)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials
NCT03217383Not ApplicableCompleted

Predictive Accuracy of MATRx Plus in Identifying Favorable Candidates for Oral Appliance Therapy

Role: lead

NCT03812692Completed

Validation of a Simplified MATRx Plus

Role: lead

NCT03627169Completed

PSG Validation of MATRx Plus AHI

Role: lead

NCT03616327Not ApplicableCompleted

Workflow Validation of an In-Home Feedback Controlled Mandibular Positioner

Role: lead

NCT03579225Completed

Improving the Efficiency of the Digital Sleep Workflow Using MATRx Plus

Role: lead

NCT03049982Not ApplicableCompleted

A Study for Obstructive Sleep Apnea Using a New At-Home Sleep Test

Role: lead

NCT02933112Not ApplicableCompleted

Workflow Validation of an In-home Auto-titrating Mandibular Positioner

Role: lead

NCT03011762Not ApplicableCompleted

Feasibility and Predictive Accuracy of an In-Home Computer Controlled Mandibular Positioner in Identifying Favorable Candidates for Oral Appliance Therapy

Role: lead

All 8 trials loaded